|
TXLNA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.936600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.989600E-01 |
| Normal-vs-Stage2 |
2.373800E-01 |
| Normal-vs-Stage3 |
8.462000E-01 |
| Normal-vs-Stage4 |
1.232620E-01 |
| Stage1-vs-Stage2 |
2.819200E-01 |
| Stage1-vs-Stage3 |
9.614800E-01 |
| Stage1-vs-Stage4 |
5.070000E-02 |
| Stage2-vs-Stage3 |
3.469000E-01 |
| Stage2-vs-Stage4 |
1.695800E-02 |
| Stage3-vs-Stage4 |
8.288100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.693000E-01 |
| Normal-vs-AfricanAmerican |
8.712800E-01 |
| Normal-vs-Asian |
1.022370E-02 |
| Caucasian-vs-AfricanAmerican |
7.673600E-01 |
| Caucasian-vs-Asian |
3.121900E-02 |
| AfricanAmerican-vs-Asian |
3.630100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.701800E-01 |
| Normal-vs-Female |
6.451900E-02 |
| Male-vs-Female |
1.767630E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.079000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.881000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.420000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.151400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.296600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.628200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.204800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.702400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.769800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.180400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.703800E-01 |
| Normal-vs-Grade 2 |
8.985200E-01 |
| Normal-vs-Grade 3 |
2.501200E-01 |
| Normal-vs-Grade 4 |
2.210400E-02 |
| Grade 1-vs-Grade 2 |
6.596600E-01 |
| Grade 1-vs-Grade 3 |
2.929000E-01 |
| Grade 1-vs-Grade 4 |
4.524200E-01 |
| Grade 2-vs-Grade 3 |
8.465700E-02 |
| Grade 2-vs-Grade 4 |
8.515900E-03 |
| Grade 3-vs-Grade 4 |
1.763160E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.149000E-01 |
| Normal-vs-ccB subtype |
8.305800E-01 |
| ccA subtype-vs-ccB subtype |
5.989400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.289000E-01 |
| Normal-vs-N1 |
2.687500E-02 |
| N0-vs-N1 |
2.618300E-03 |
|
|
